These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32671615)

  • 1. Impact of steroids and steroid-sparing agents on quality of life in children with nephrotic syndrome.
    Khullar S; Banh T; Vasilevska-Ristovska J; Chanchlani R; Brooke J; Licht CPB; Reddon M; Radhakrishnan S; Piekut M; Langlois V; Aitken-Menezes K; Pearl RJ; Hebert D; Noone D; Parekh RS
    Pediatr Nephrol; 2021 Jan; 36(1):93-102. PubMed ID: 32671615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.
    Harambat J; Godron A; Ernould S; Rigothier C; Llanas B; Leroy S
    Pediatr Nephrol; 2013 Apr; 28(4):631-8. PubMed ID: 23179197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome.
    Banh THM; Hussain-Shamsy N; Patel V; Vasilevska-Ristovska J; Borges K; Sibbald C; Lipszyc D; Brooke J; Geary D; Langlois V; Reddon M; Pearl R; Levin L; Piekut M; Licht CPB; Radhakrishnan S; Aitken-Menezes K; Harvey E; Hebert D; Piscione TD; Parekh RS
    Clin J Am Soc Nephrol; 2016 Oct; 11(10):1760-1768. PubMed ID: 27445165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term obesity prevalence and linear growth in children with idiopathic nephrotic syndrome: is normal growth and weight control possible with steroid-sparing drugs and low-dose steroids for relapses?
    Göknar N; Webb H; Waters A; Tullus K
    Pediatr Nephrol; 2022 Jul; 37(7):1575-1584. PubMed ID: 34767076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome.
    Meuleman MS; Guilmin-Crépon S; Hummel A; Daugas E; Dumas A; Leye F; Dantal J; Rigothier C; Provot F; Chauveau D; Burtey S; Hertig A; Dahan K; Durrbach A; Dossier C; Karras A; Guerrot D; Esnault V; Rémy P; Massy ZA; Tostivint I; Morin MP; Zaoui P; Fritz O; Le Quintrec M; Wynckel A; Bourmaud A; Boyer O; Sahali D; Alberti C; Audard V; Mellerio H
    J Nephrol; 2022 May; 35(4):1123-1134. PubMed ID: 34224090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidimensional impact on families of children with steroid-sensitive nephrotic syndrome.
    Dhooria GS; Singh HP; Bhat D; Bains HS; Soni RK; Kumar M
    J Paediatr Child Health; 2017 Apr; 53(4):354-357. PubMed ID: 28058746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Childhood steroid-dependent idiopathic nephrotic syndrome: Predictive factors for the need of immunosuppressive treatment].
    Golay M; Douillard A; Nagot N; Fila M; Ichay L; Dalla Vale F; Tenenbaum J; Morin D
    Arch Pediatr; 2017 Nov; 24(11):1096-1102. PubMed ID: 28941627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.
    Selewski DT; Troost JP; Cummings D; Massengill SF; Gbadegesin RA; Greenbaum LA; Shatat IF; Cai Y; Kapur G; Hebert D; Somers MJ; Trachtman H; Pais P; Seifert ME; Goebel J; Sethna CB; Mahan JD; Gross HE; Herreshoff E; Liu Y; Carlozzi NE; Reeve BB; DeWalt DA; Gipson DS
    Health Qual Life Outcomes; 2017 Aug; 15(1):166. PubMed ID: 28835233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice variations in the management of childhood nephrotic syndrome in the Netherlands.
    Schijvens AM; van der Weerd L; van Wijk JAE; Bouts AHM; Keijzer-Veen MG; Dorresteijn EM; Schreuder MF
    Eur J Pediatr; 2021 Jun; 180(6):1885-1894. PubMed ID: 33532891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Pravitsitthikul N; Willis NS; Hodson EM; Craig JC
    Cochrane Database Syst Rev; 2013 Oct; (10):CD002290. PubMed ID: 24166716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of relapses with levamisole as adjuvant therapy in children with a first episode of idiopathic nephrotic syndrome: study protocol for a double blind, randomised placebo-controlled trial (the LEARNS study).
    Veltkamp F; Khan DH; Reefman C; Veissi S; van Oers HA; Levtchenko E; Mathôt RAA; Florquin S; van Wijk JAE; Schreuder MF; Haverman L; Bouts AHM
    BMJ Open; 2019 Aug; 9(8):e027011. PubMed ID: 31375606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioning.
    O'Mahony J; Marrie RA; Laporte A; Bar-Or A; Yeh EA; Brown A; Dilenge ME; Banwell B
    Mult Scler; 2019 Oct; 25(12):1661-1672. PubMed ID: 30160208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome.
    Elmas AT; Tabel Y; Elmas ON
    Int Urol Nephrol; 2013 Aug; 45(4):1047-55. PubMed ID: 22826143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole treatment in steroid-sensitive and steroid-resistant nephrotic syndrome.
    Tenbrock K; Müller-Berghaus J; Fuchshuber A; Michalk D; Querfeld U
    Pediatr Nephrol; 1998 Aug; 12(6):459-62. PubMed ID: 9745868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Dose of Rituximab in Children with Steroid-Dependent / Frequently Relapsing Nephrotic Syndrome, Clinical Efficacy and Evaluation of Health-Related Quality of Life.
    Wang L; Hua R; Zhu Y; Lu Y; Gao H; Xia X; Zhang Q; Lu L; Deng F
    Iran J Kidney Dis; 2021 Mar; 1(2):109-115. PubMed ID: 33764321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in children with nephrotic syndrome: a cross-sectional study using Hindi version of PedsQL 4.0 Generic Core Scales.
    Mazahir R; Anand K; Pruthi PK
    Clin Exp Nephrol; 2022 Jun; 26(6):552-560. PubMed ID: 35106675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.